Evidence map›Paper›PMID 22422883›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Early induction of CCL7 downstream of TLR9 signaling promotes the development of robust immunity to cryptococcal infection.

Yafeng Qiu, Stuart Zeltzer, Yanmei Zhang, Fuyuan Wang, Gwo-Hsiao Chen, Jeremy Dayrit, Benjamin J Murdock, Urvashi Bhan, Galen B Toews, John J Osterholzer and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 53 citations in OpenAlex.

  1. TREM2 drives monocyte-derived macrophage responses tobioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Dendritic Cells: Multifunctional Roles in Host Defenses toJournal of fungi (Basel, Switzerland) · 2023
    Review
  5. Innate Pulmonary Phagocytes and Their Interactions with PathogenicJournal of fungi (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Transcriptional profiling of a fungal granuloma reveals a low metabolic activity ofFrontiers in cellular and infection microbiology · 2023
    Article
  8. Pulmonary Fibrosis and Hypereosinophilia in TLR9Pathogens (Basel, Switzerland) · 2022
    Article
  9. Influence of Pathogen Carbon Metabolism on Interactions With Host Immunity.Frontiers in cellular and infection microbiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Innate Immune Responses toJournal of fungi (Basel, Switzerland) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yafeng QiuDepartment of Research Service, Veterans Administration Ann Arbor Health System, Ann Arbor, MI 48105, USA.
Stuart Zeltzer
Yanmei Zhang
Fuyuan Wang
Gwo-Hsiao Chen
Jeremy Dayrit
Benjamin J Murdock
Urvashi Bhan
Galen B Toews
John J Osterholzer
Theodore J Standiford
Michal A Olszewski
University of Michigan–Ann Arbor · USVA Ann Arbor Healthcare System · US

Funding

Role of TLR9 in Lung Antibacterial Host DefenseR01HL057243 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STANDIFORD, THEODORE J. · 1997 to 2011
$3.6M
TLR9 Mediated Dendritic Cell Responses in Hypersensitivity PneumonitisK08HL094762 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BHAN, URVASHI · 2009 to 2013
$667k
NHLBI NIH HHS HL25243NHLBI NIH HHS HL97456NHLBI NIH HHS K08 HL094762NHLBI NIH HHS K08-HL094762NHLBI NIH HHS R01 HL057243
6 · The paper itself

Abstract

We investigated mechanisms by which TLR9 signaling promoted the development of the protective response to Cryptococcus neoformans in mice with cryptococcal pneumonia. The afferent (week 1) and efferent (week 3) phase immune parameters were analyzed in the infected wild-type (TLR9(+/+)) and TLR-deficient (TLR9(-/-)) mice. TLR9 deletion diminished 1) accumulation and activation of CD11b(+) dendritic cells (DCs), 2) the induction of IFN-γ and CCR2 chemokines CCL7, CCL12, but not CCL2, at week 1, and 3) pulmonary accumulation and activation of the major effector cells CD4(+) and CD8(+) T cells, CD11b(+) lung DCs, and exudate macrophages at week 3. The significance of CCL7 induction downstream of TLR9 signaling was investigated by determining whether CCL7 reconstitution would improve immunological parameters in C. neoformans-infected TLR9(-/-) mice. Early reconstitution with CCL7 1) improved accumulation and activation of CD11b(+) DCs at week 1, 2) restored early IFN-γ production in the lungs, and 3) restored the accumulation of major effector cell subsets. CCL7 administration abolished the difference in lung fungal burdens between TLR9(+/+) and TLR9(-/-) mice at week 3; however, significant reduction of fungal burdens between PBS- and CCL7-treated mice has not been observed, suggesting that additional mechanism(s) apart from early CCL7 induction contribute to optimal fungal clearance in TLR9(+/+) mice. Collectively, we show that TLR9 signaling during the afferent phase contributes to the development of protective immunity by promoting the early induction of CCL7 and IFN-γ and the subsequent early recruitment and activation of DCs and additional effector cells in mice with cryptococcal pneumonia.

Indexed as

Cryptococcus neoformansAnimalsCD11b AntigenCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell CommunicationChemokine CCL7Colony Count, MicrobialCryptococcosisDendritic CellsFemaleInterferon-gammaLungMacrophagesMiceMice, Inbred BALB CCcl12 protein, mouseCD11b AntigenChemokine CCL7Interferon-gammaMonocyte Chemoattractant ProteinsTlr9 protein, mouseToll-Like Receptor 9

Identifiers

PMID22422883
PMCPMC3324623
OpenAlexW2163540334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.